Bristol Myers Squibb - Redefining the treatment paradigm for non-small cell lung cancer (NSCLC): Innovations on the horizon

Name: Bristol Myers Squibb - Redefining the treatment paradigm for non-small cell lung cancer (NSCLC): Innovations on the horizon
Start: 2026-12-05T12:45
End: 2026-12-05T14:15
Location: Suntec Convention Centre

ESMO Asia 2026 · 5 December 2026 · 12:45–14:15 · Room 310

Bristol Myers Squibb - Redefining the treatment paradigm for non-small cell lung cancer (NSCLC): Innovations on the horizon was a session at ESMO Asia 2026 on 5 December 2026 in Singapore, with 3 speakers on record.

Speakers

Hidetoshi Hayashi — Panelist Kindai University - Faculty of Medicine
Kenneth J. O'Byrne — Panelist Princess Alexandra Hospital - Metro South Health
Solange Peters — Chair CHUV - Centre Hospitalier Universitaire Vaudois